Bladder cancer vaccine - Organon Teknika
Alternative Names: OncoTICELatest Information Update: 24 Oct 2021
At a glance
- Originator Organon Teknika
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Bladder cancer
Most Recent Events
- 29 Dec 1999 New profile, split from generic Bladder cancer vaccine profile